echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > J clin oncol: The influence of donor clonal hematopoiesis on the clinical prognosis of hematopoietic cell transplant recipients

    J clin oncol: The influence of donor clonal hematopoiesis on the clinical prognosis of hematopoietic cell transplant recipients

    • Last Update: 2021-12-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Clonal hematopoietic (CH) is an age-related asymptomatic disease.


    In allogeneic hematopoietic cell transplantation, if the donor has clonal hematopoiesis, the recipient may obtain clonal hematopoiesis after hematopoietic cell transplantation


    immunity

    Researchers such as Christopher performed targeted error-correction sequencing on samples from 1727 bone marrow donors ≥40 years of age, and evaluated the impact of donor clonal hematopoiesis on the clinical outcome of recipients


    22.


    22.


    The correlation between DNMT3A-CH and the risk of receptor recurrence

    The correlation between DNMT3A-CH and the risk of receptor recurrence

    In patients receiving calcineurin-based graft-versus-host disease prevention strategies, the donor DNMT3A-CH and the recipient had fewer recurrences (HR 0.


    Prevention of donor DNMT3A-CH was associated with decreased recipient recurrence (HR 0.


    The relationship between DNMT3A-CH and the risk of chronic graft-versus-host disease in the recipient

    The relationship between DNMT3A-CH and the risk of chronic graft-versus-host disease in the recipient

    No single DNMT3A-CH or TET2-CH recipient has developed donor cell leukemia (DCL)


    Among the 8 cases of DCL, 7 cases evolved from donor clonal hematopoietic donor cells carrying rare TP53 mutations or splicing factor mutations or donor cells carrying germline DDX41 mutations


    Donor clonal hematopoiesis is closely related to the clinical prognosis of transplant recipients Donor clonal hematopoiesis is closely related to the clinical prognosis of transplant recipients

    Original source:

    Original source:

    Christopher J.


    Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation

    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.